Depression increases risk of cardiac events after coronary artery bypass surgery

November 22, 2001

N.B. Please note that if you are outside North America please note that the embargo for Lancet press material is 0001 hours UK Time Friday 23 November 2001.

A study in this week's issue of THE LANCET highlights how depression is an important independent risk factor for cardiac events after coronary artery bypass graft (CABG) surgery. The study showed that depressed patients are more than twice as likely as non-depressed patients to die or be readmitted for cardiac causes in the 12 months after discharge from hospital.

The association of depression with adverse cardiac events has been investigated mainly in community populations, in patients undergoing catheterisation, or in patients who have had a heart attack. Ingrid Connerney and colleagues from the University of Maryland Medical Center and Columbia University College of Physicians & Surgeons, USA, assessed the effect of depression on outcomes after CABG surgery.

207 men and 102 women who had undergone CABG surgery were prospectively followed up for one year. Depression was assessed with a structured psychiatric interview (diagnostic interview schedule) and a questionnaire (Beck depression inventory) before discharge from hospital. Cardiac events included angina or heart failure that needed admission to hospital, heart attack, percutaneous transluminal coronary angioplasty, repeat CABG, and cardiac death. Non-cardiac events consisted of all other reasons for death or readmission to hospital.

63 patients (20%) were identified as having a major depressive disorder. At 12 months follow-up, 17 (27%) of these patients had a cardiac event compared with 25 of 246 (10%) who were not depressed. In addition to depression, four other factors had significant univariate associations with cardiac events: female gender, living alone, low ejection fraction of blood from the right ventricle (less than 0·35), and length of hospital stay. Depression did not predict deaths or admissions for non-cardiac events.

Ingrid Connerney comments: "Depression is thought of as an understandable and inevitable reaction to the severe circumstances accompanying CABG surgery, and as a result, it is not always treated. Data from this and other studies suggest that since the prevalence of depression is 20-25%, it is not an inevitable consequence of CABG surgery. Because depression after CABG surgery is associated with a significant independent risk of adverse cardiac events in the 12 months after surgery, would treatment of depression reduce adverse cardiac outcomes? Although assessment of depression in patients who have had cardiac events is difficult because symptoms of depression and cardiac disease overlap, results of many studies show that assessment of depression is not only possible, but could also be clinically important. In view of the strong relation between depression and adverse cardiac events, studies should be done to ascertain whether treatment of depression can reduce cardiac events after CABG surgery."
-end-
Contact: Dr Ingrid Connerney, c/o Ellen Beth Levitt, Director, Media Relations, University of Maryland Medical System and University of Maryland School of Medicine, 22 South Greene St., Baltimore, Maryland 21201, USA; T)+1 410 328 8919; M) +1 410 598 4711; E) EBLEVITT@umm.edu

Lancet

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.